Remove 2021 Remove Conditions Remove Data Remove Media
article thumbnail

SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May 2021

Cannabis Law Report

. (“ SOL Global ” or the “ Company “) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to provide its investors with unaudited financials for the second quarter ended May 31, 2021, and other highlights for the interim period. million for the six-months ended May 31, 2021, compared to $27.4 at May 31, 2020.

Events 105
article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100
article thumbnail

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Cannabis Law Report

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And

Data 52
article thumbnail

Medxtractor Doubles Down on B2B Licensing & mHealth

Cannabis Law Report

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

article thumbnail

MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD

Cannabis Law Report

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

article thumbnail

SOL Global Provides Interim Unaudited Financials for the Third Quarter Ended August 2021

Cannabis Law Report

. (“ SOL Global ” or the “ Company “) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to present its investors with select unaudited financial results and highlights for the three and nine-month period ended August 31, 2021. For the three-months ended August 31, 2021, the Company recorded a loss of $(62.4)

Events 52